本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nutriband Inc.

6.96
+0.880014.47%
盤後6.87-0.0879-1.26%19:49 EDT
成交量:9.98萬
成交額:65.59萬
市值:8,473.72萬
市盈率:-12.13
高:6.97
開:6.18
低:6.09
收:6.08
52周最高:8.63
52周最低:2.80
股本:1,217.49萬
流通股本:542.12萬
量比:0.95
換手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):-0.5739
每股收益(LYR):-2.5809
淨資產收益率:-100.75%
總資產收益率:-53.48%
市淨率:15.91
市盈率(LYR):-2.70

資料載入中...

公司資料

公司名字:
Nutriband Inc.
交易所:
NASDAQ
成立時間:
2016
員工人數:
- -
公司地址:
121 South Orange Avenue,Suite 1500,Orlando,Florida,United States
郵編:
32801
電話:
傳真:
- -
簡介:
Nutriband Inc.是一家內華達州公司,成立於2016年1月4日。他們主要從事透皮藥物產品組合的開發。他們的主要產品是他們的濫用威懾芬太尼透皮系統,他們正在開發為臨床醫生和患者提供一種緩釋芬太尼透皮產品,用於治療需要全天候阿片類藥物治療的慢性疼痛,並結合旨在通過阻止濫用和誤用芬太尼貼片來幫助對抗阿片類藥物危機的特性。

董事

名稱
職位
Gareth Sheridan
Chief Executive Officer and Director
Serguei Melnik
Chairman of the Board and Director and President and Secretary
Alessandro Puddu
Independent Director
Irina Gram
Independent Director
Mark Hamilton
Independent Director
Radu Bujoreanu
Independent Director
Sergei Glinka
Independent Director
Stefani Mancas
Independent Director
Viorica Carlig
Independent Director

股東

名稱
職位
Gareth Sheridan
Chief Executive Officer and Director
Alan Smith
Chief Operating Officer and President of 4P Therapeutics
Gerald Goodman
Chief Accounting Officer and Chief Financial Officer
Jeff Patrick
Chief Scientific Officer
Serguei Melnik
Chairman of the Board and Director and President and Secretary